Page last updated: 2024-11-07

n-acetyldaunomycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-acetyldaunomycin: RN given refers to (8S-cis)- isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID24191042
CHEMBL ID45945
SCHEMBL ID1399850
MeSH IDM0042351

Synonyms (4)

Synonym
n-acetyldaunomycin
CHEMBL45945
SCHEMBL1399850
n-[6-[[(1s,3s)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1h-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]acetamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID99472Tested for the cytotoxicity (continuous incubation) against L1210 leukemia cells determined by clonogenic assay.1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
Structure-activity relationship of anthracyclines in vitro.
AID99471Tested for the cytotoxicity(1 hour incubation) against L1210 leukemia cells.1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
Structure-activity relationship of anthracyclines in vitro.
AID21036Tested for the partition coefficient between water and n-octanol.1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
Structure-activity relationship of anthracyclines in vitro.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (75.00)18.7374
1990's2 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]